Abstract
The World Health Organization issued a nitrosation procedure (NAP Test) which allows to carry out nitrosation under standard conditions. It has proved that the in vitro reaction rates of the fast nitrosatable drugs piperazine, cimetidine and ethambutol are not influenced by α-, β- and γ-cyclodextrin. On the contrary, β-, γ-cyclodextrin and heptakis-2,6-di-O-methyl-β-cyclodextrin enhance the nitrosation of the slower nitrosatable 1-ephedrine and fencamfamine significantly. This possible reaction must be considered if nitrosatable drugs are formulated with cyclodextrins to be administered to human beings.
Similar content being viewed by others
References
F. Foulsten, J.F. Dunne: ‘The Potential Carcinogenicity of Nitrosatable Drugs’,WHO Symposium Geneva, June 1978
J. Szejtli, A. Liptak, P. Fügedi, P. Nanasi, A. Neszmelyi:Stärke 32, 165 (1980)
B. Casu, M. Reggiani, G.G. Gallo, A. Vigevani:Tetrahedron 24, 803 (1968)
S.S. Mirvish:Toxicol. Appl. Pharmacol. 31, 325 (1975)
G. Lambrecht:Pharmazie heute (BeilageDtsch. Apoth. Ztg.)3, 85 (1981)
F. Cramer, F.M. Henglein:Chem. Ber. 90, 2561 (1957)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frömming, K.H., Wedelich, V. & Mehnert, W. Influence of cyclodextrins on nitrosation of drugs. Journal of Inclusion Phenomena 2, 605–611 (1984). https://doi.org/10.1007/BF00662226
Issue Date:
DOI: https://doi.org/10.1007/BF00662226